éŠã®ç®èã¯é ãäžãããã³ã«åãäœçœ®ã§æããè¥ã®å€ã§æ¥å ãåããŸããæšªã«å¹ãã ç·ã¯ãã®æããšåŒŸåäœäžãæ®ããè·¡ã§ãããçžŠã«æµ®ãåºãçã¯éŠã®åã®çèãåçž®ãããšãã«ç®ç«ã¡ãŸãã
å€çšã±ã¢ãšæ³šå°ã¯ããã®äºã€ãåããããšã«æ±ºããŸããç·ããšã«æ ãæ³šå°ãåãããŸãã
3è¡ãŸãšã
1. 暪ã®ç·ã¯ãã¢ã«ãã³é žã瞊ã®çèã®çã¯ãããã¯ã¹ã§åããŸãã
2. 暪ã®ãã¢ã«ãã³é žã¯éããç ç©¶ã§1幎以å ã«åã³åããå²åãååã§ããã
3. æ¥çŒãæ¢ãã¯SPF 30以äžãå€åº15ååã2æéããšã«å¡ãè¶³ããç»é¢ã¯ç®ã®é«ãè¿ãã«æã¡ãŸãã
暪ã«å¹ãã ç·ãšçžŠã«æµ®ãåºãç
åãæããéŠãèŠããšãã«æšªã®æºãæ®ã£ãŠããã°ãèçã»åŒŸåã«è¿ãã§ããæ¯ãé£ããã°ã£ããéŠãç·åŒµãããããããšãã ã瞊ã®çãæµ®ãäžãããªããéŠã®åã®çèåŽã§ããäžã€ã®éŠã«äºçš®é¡ãéãªãããšãå€ããããŸãã
| åºå | 暪ã«å¹ãã ç· | çžŠã«æµ®ãåºãç |
|---|---|---|
| ãã€èŠããã | åãæããç¶æ ã§ãæºãæ®ã | éŠãç·åŒµããããšãã«åž¯ã®ããã«æµ®ãäžãã |
| äž»ãªåå | ç¹°ãè¿ãã®æãã匟åäœäžãèç©ããæ¥å | éŠã®åã®çèã®åçž® |
| å ã«èŠãæœè¡ | ãã¢ã«ãã³é žæ³šå° | ãããã¯ã¹ |
æãã»æ¥å ã»çèãäžç·ã«ç©ã¿éãªããŸã
幎霢局ããšã«éŠã枬ã£ã枬å®ã§ã硬ããšåŒŸåã¯è¥ãå±€ãã幎霢ã®é«ãå±€ãžåããã»ã©èœã¡ãçèãåããšãã«ç®èãæŒãæµãããè·é¢ã¯å¢ããŸãããæšªã®æºã¯ãã®ããã«æ·±ããªããŸãã
æ¥å ã¯ç®èèåã®äž»èŠãªç°å¢èŠå ã§ããéŠã¯é¡ããæ¥çŒãæ¢ããå¡ãå¿ããããäœçœ®ã§ãè¥ã®å€ã«åºãç®èããã®ãŸãŸé²åºããŸãã
ã¹ããŒããã©ã³ã»ã¿ãã¬ãããèŠããšããéŠã¯åã«æ²ãããŸããæ©åšã®äœ¿çšãšéŠã®éªšã®å匯ãäžç·ã«æž¬ã£ãèšé²ãããããã®å§¿å¢ãåãç®èãç¹°ãè¿ããŠæããŸãã
éŠãŸã§æ¥çŒãæ¢ããç»é¢ã¯ç®ã®é«ã
ãã§ã«å¹ãã æºã¯å§¿å¢ãçŽããŠãæ·±ããæ®ããŸããä»åŸã®æããšæ¥å ã®èç©ãæžããããšã¯ãæœè¡ã®åã§ããæœè¡ã®ããšã§ãåãã§ããç±³åœç®èç§åŠäŒã¯ãè¡£æã§èŠã£ãŠããªãç®èã«SPF 30以äžã玫å€ç·Aã»Bããšãã«é²ã補åãå€åº15ååã«å¡ãã2æéããšã»æ°Žæ³³ã»æ±ã®çŽåŸã«å¡ãè¶³ãããæ¡å ããŠããŸããéŠã»è³ã®äžã»åèžããã®äœçœ®ã«å ¥ããŸãã補åã®éžã³æ¹ã¯æ¯æ¥æ¥çŒãæ¢ããå¡ãæ¹æ³ã§ç¶ããŠèŠãããŸãã
ç»é¢ã¯ç®ã®é«ãè¿ãã«æã¡ãã¢ãã¿ãŒãé ãäžããªãé«ãã«äžããŸããæŽé¡ã®ããšé¡ãšäžç·ã«éŠãŸã§ä¿æ¹¿å€ãå¡ããŸãã
暪ã®ç·ã¯ãã¢ã«ãã³é žã瞊ã®çã¯ãããã¯ã¹
æšªã®æºã«ã¯ãã¢ã«ãã³é žãç®èã®æµ ãã«å ¥ããæ³šå°ãè€æ°ã®ç ç©¶ã§äœ¿ãããŸãããéããåæã§èŠãç®ã®ç¹æ°ãäžããã1幎以å ã«åã³åããå²åã¯ååã§ãããå ±åãããåå¿ã¯å åºè¡ã»ããã¿ã»å§çã®ããã«è»œãçãéããŸãããèçãã¿ã泚å°ã®çš®é¡ã¯ã¹ãã³ããŒã¹ã¿ãŒçš®é¡æ¡å ã§ç¢ºèªã§ããŸãã
瞊ã®çã«ã¯ãããã¯ã¹ãéŠã®åã®çèããã°ãã匱ããåž¯ãæµ®ãäžããã«ããããŸããç±³åœèš±å¯ã©ãã«ã®ç¯å²ã¯ãæäººã«ãããäžç床以äžã®éŠã®åã®çèã®çã®äžæçãªæ¹åã§ããèš±å¯ã®æ ¹æ èšåºã¯è£œé äŒç€Ÿè©Šéšã§ãããçŠå¿ã¯è£œå€éæãšæ³šå°éšäœã®ææã§ããéŠã®çèã匱ããæ³šå°ã®ããã飲ã¿èŸŒã¿ã»è©±ã声ã®å€åãããã°äºçŽåã«ç¥ãããŸããçšéã»äœçœ®ã¯ãããã¯ã¹æœè¡æ¡å ãšãããã¯ã¹ vs ãã£ã©ãŒæ¯èŒã§ç¶ããŠèŠãããŸãã
é¡ã®ã©ã€ã³ããŒãããéŠã®ç®èããããã§èŠããå Žåãéæè¶ 鳿³¢ïŒãŠã«ã»ã©ïŒãé¡äžã»éŠã®ãããã çµç¹ãæã¡äžããçšéã§åžè²©ãããŠããŸããåžè²©ææžã®å ¬é詊éšã§æå®³åå¿ã¯è»œãçãéããéå€§ãªæ©åšé¢é£äºè±¡ã¯0ä»¶ãšéèšãããŸããã女æ§ã®è»œåºŠã»äžç床ã®ããã¿ãéããæç®ã®æåŸã®æç¹ã¯1幎ã§ããåçãšé¡ã®ããã¿ãšã®éãã¯ãŠã«ã»ã©æœè¡æ¡å ãšé¡ã®ããã¿æ¹åæ¡å ã§èŠãããŸãã
| é ç® | ãã¢ã«ãã³é ž | ãããã¯ã¹ | éæè¶ 鳿³¢ |
|---|---|---|---|
| æ ãäœçœ® | 暪ã«å¹ãã æºã»èç | 瞊ã®çèã®ç | é¡äžã»éŠã®ãããã çµç¹ |
| ããããš | ç®èã«å ¥ããŠæºã»èçãã¿ã | éŠã®åã®çèããã°ãã匱ãã | æ·±ãå±€ã«ç±ãéããŠåŒãç· ãã |
| æ¥çš | è€æ°åã«åãã | 1åã®ããšãåãæ»ã£ããåã³ | 1åã®ããšãæ°ãæãããŠã¿ã |
| åœæ¥ã®åå¿ | å åºè¡ã»ããã¿ã»å§ç | 泚å°éšäœã®åå¿ã飲ã¿èŸŒã¿ã»è©±ã声 | èµ€ã¿ã»ããã¿ã»çã¿ |
â» ãã¢ã«ãã³é žã®åæœè¡å²åã¯è€æ°ã®ç ç©¶ãéããåæããããã¯ã¹ã®ç¯å²ã¯ç±³åœèš±å¯ã©ãã«ãè¶ é³æ³¢ã®çšéã¯åžè²©ææžåºæºã§ããåæ°ã»è£œåãç°ãªããããè²»çšã¯ã«ãŠã³ã»ãªã³ã°èŠç©ããã§åããŸãã
äºçŽåã«éŠãèŠãªããå°ããããš
以äžããã®ãŸãŸå°ãããšã仿¥æ±ãç·ãšæ³šå°ãåãããŸãã
- â¡ åãæããéŠã§æšªã®æºãèŠããããç·åŒµãããšãã ã瞊ã®çãæµ®ãäžããã
- â¡ é¡ã®ã©ã€ã³ããŒãããŠããããæšªã®æºã ãããäž¡æ¹ã
- â¡ ãããã¯ã¹ã䜿ãå Žåã飲ã¿èŸŒã¿ã»è©±ã声ãã©ãã¿ãã
- â¡ ãã¢ã«ãã³é žãå ¥ããæ·±ããšåæ°
- â¡ éŠã®æè¡ã»é žæ€ã®çã¿ãåŠåš ã»æä¹³ãæ³šå°éšäœã®ççãæååºè¬
泚å°éšäœã®äžæçãªèµ€ã¿ã»ããã¿ã»å åºè¡ã¯å ±éã§ããå ±éã®æ³šæã¯æœè¡å®å šæ¡å ã§ã確èªãã ããã
ãããã質å
Q1. éŠã®æ³šå°ã¯çãã§ããïŒ
éãå ¥ããšãã«ãã¯ããšããŸããéŠã¯å åºè¡ããããã»ãã§ã麻é ã¯ãªãŒã ãå¡ã£ãŠé²ããããšãå€ããããŸããåœæ¥ã¯åŒ·ãããã£ããããµãŠãã¯é¿ããŠãã ããã
Q2. ãã¢ã«ãã³é žã¯äœååããŸããïŒ
äžåºŠã§çµããæ¥çšãããééã眮ããŠè€æ°åå ¥ããæ¯èŒããããŸãã補é äŒç€Ÿè³éã§å®æœãããäžã€ã®æ¯èŒã¯4é±ééã§3åã§ãããåæ°ã¯è£œåãšæºã®æ·±ãã«åãããŠçµã¿ãŸãã
Q3. ãããã¯ã¹ã®éŠãã³ãã¯ã©ã®ãããæã¡ãŸããïŒ
çèã®åãæ»ããšçãåã³èŠããŸããæ¬¡ã®æ¥çšã¯åãæ»ãæç¹ãš3ãæééãããããŠèŠãŠçµã¿ãŸãã
Q4. æšªã®æ³šå°ãšãããã¯ã¹ãäžç·ã«åããŠãããã§ããïŒ
èçã®æ³šå°ãšçèã®æ³šå°ã¯å¯Ÿè±¡ãç°ãªããããäžã€ã®èšç»ã®äžã«çœ®ãå ŽåããããŸããåãæ¥ã«å ¥ãããã¯ãããã¿ãéãªãäœçœ®ãèŠãŠæ±ºããŸãã
Q5. èª°ãæ¥çšãå»¶æããŸããïŒ
泚å°éšäœã«ççãããã°æ¥çšãå»¶æããŸãããããã¯ã¹è£œå€ã¢ã¬ã«ã®ãŒãåŠåš ã»æä¹³ãç¥çµççŸæ£ããã§ã«é£²ã¿èŸŒã¿ãé£ããç¶æ ãæååºè¬ã¯äºçŽåã«ç¥ãããŸãã
çµæã»æç¶ã»é©åã®å¯åŠã¯ããäžäººãã²ãšãã®èç¶æ ã»å¹Žéœ¢ã»çæŽ»ç¿æ £ã«ãã£ãŠå·®ããããåãçµæããçŽæããããšã¯ã§ããŸããã
æœè¡ã«ã¯äžæçãªèµ€ã¿ã»ããã¿ãªã©ã®å¯åå¿ãçããå¯èœæ§ããããçŠå¿äºé ãããå ŽåããããŸãã®ã§ãäºåã«ãŠã³ã»ãªã³ã°ã§ã確èªãã ããã
æ¬èšäºã¯äžè¬çãªæ å ±ã®ãæ¡å ã§ãããåå¥ã®èšºçã«ä»£ãããã®ã§ã¯ãããŸããããèªèº«ã®ç¶æ ã«åããã蚺æã»æœè¡ã¯ã«ãŠã³ã»ãªã³ã°ã§ã確èªãã ããã
æ ¹æ è³æ
- ç±³åœFDAãBOTOX Cosmeticèš±å¯ã©ãã«(2024) â PDFæ¬æãæäººã«ãããéŠã®åã®çèæŽ»åã«é¢é£ããäžç床以äžã®çžŠã®ç(platysma bands)ã®äžæçæ¹åãçŠå¿=補å€éæã»æ³šå°éšäœææãåŠåš ã¯é©åãªèšåºã»åžè²©åŸè³æããªããšèšèŒã飲ã¿èŸŒã¿ã»åŒåžå°é£ã®èŠåãéŠãã³ãé ç®ã®æå®³åå¿è¡šã¯ãä»ã®é©å¿ãšåãããšã®ã¿èšèŒãæ£è æ¡å : 18æ³æªæºã¯æšå¥šããªãã3ãæããé »ç¹ãªå埩ã®å®å šã»å¹æã¯è©äŸ¡ãããŠããªããèš±å¯æ ¹æ ã®äºã€ã®è©Šéšã¯è£œé äŒç€Ÿ(AbbVie)ç»é²è©Šéšã
- PMID 41612547 SyedããéŠã®åã®çèã®çã®ãããã¯ã¹ç¡äœçºè©ŠéšéãŸã(æé²+PMCæ¬æ)ãèè ã®å©ççžåãªããäžè©Šéšã1段éã»2段éã®æ¹åããã©ã»ãããå€ããæå®³åå¿ã®çºçã¯çŸ€éã§åçšåºŠãæ°åã¯å詊éšã補é äŒç€Ÿã®èš±å¯æ ¹æ 詊éšã®ããæ¬æã«å ¥ãããEurope PMCã«æ€åã»æžå¿µè¡šæãªãã
- PMID 41560960 Wongããæšªã®éŠãããã¢ã«ãã³é žã®éãŸãåæ(æé²+PMCæ¬æ)ãç ç©¶è²»ã»å©ççžåãªã宣èšã11ç·šãèŠãç®ç¹æ°ã®äžæã12ãæä»¥å ã®åæœè¡å²å50%ãå䜵ç14%ã§å åºè¡ã»ããã¿ã»å§çãªã©è»œãçããæ ¹æ ã¬ãã«4ã補åã»æ³šå ¥æ³ããŸã¡ãŸã¡ãEurope PMCã«æ€åãªãã
- PMID 41873431 Jiangããéæ¶æ©ãã¢ã«ãã³é žè€åæ¶²ã®éŠããæ¯èŒ(æé²+PMCæ¬æ)ãLaboratoires FILL-MEDç ç©¶è²»ïŒè©Šéšæ©åšã»æ€æ»è²»ã»äº€éè²»ïŒã188åã4é±éé3åãæåŸã®æ³šå°ã®4é±åŸã®åå¿çã¯äºã€ã®è£œåãåçšåºŠãæ©åšã»æœè¡é¢é£ã®éå€§ãªæå®³åå¿0ãæ¬æFAQã®3åã»4鱿¥çšã®ã¿äœ¿çšã
- ç±³åœFDAãUlthera Systemåžè²©èŠçŽ(2012) â PDFæ¬æãçæ¯æäžã«å ããé¡äžã»éŠã®ãããã çµç¹ãæã¡äžããçšéãå ¬é詊éš70åäž51åã§å®ããé¢ç©åºæºã®æ¹åããã¡é ããè©äŸ¡84.3%ãæå®³åå¿ã¯è»œãçããéå€§ãªæ©åšé¢é£äºè±¡0ãé¢ç©åäœã¯æ¬æã«å ¥ããã
- PMID 36674277 Continiããéæè¶ 鳿³¢ã®é¡ã»é¡äžéãŸã(æé²+PMCæ¬æ)ãç ç©¶è²»ãªãã»å©ççžåãªãã16ç·šã察象ã¯å¥³æ§ãå»åž«ç¹æ°ãšåãã人ã®ç¹æ°ã®å·®ãäžç床ã®çã¿ãæ±ã£ãæåŸã®æç¹1幎ãããã¿ã»äœæ Œã倧ãã矀ã§åå¿æžå°ãEurope PMCã«æ€åãªãã
- PMID 35701594 CotofanaããéŠç®èã®åŒŸåã»çèæŽ»å(æé²ã®ã¿)ã77åãè¥ãã»äžéã»å¹Žéœ¢ã®é«ãå±€ã«åãã硬ãã»åŒŸåã¯å¹Žéœ¢ãé«ãã»ã©äœããçèåçž®æã®ç®èç§»åã¯å¢ãããæœè¡å¹æã枬ã£ãç ç©¶ã§ã¯ãªããPMCãªããEurope PMCã«æ€åãªãã
- PMID 12437452 Fisherããå èåæ©åºã¬ãã¥ãŒ(æé²ã®ã¿)ãæ¥å ãç®èèåã®äž»èŠãªç°å¢èŠå ãšããŠæŽçãéŠæœè¡ã®å¹æã¯æž¬å®ããŠããªããEurope PMCã«æ€åãªãã
- PMID 29610602 ÃÄrenciããæ©åšäœ¿çšãšéŠã®éªšã®å匯(æé²+PMCæ¬æ)ãéŠã®çã¿ã§æ¥ã156åãäœ¿çšæé(æéÃ幎)ãšé žæ€å匯è§åºŠãæ¯èŒãããã®æ·±ããæž¬ã£ãç ç©¶ã§ã¯ãªããEurope PMCã«æ€åãªãã
- ç±³åœç®èç§åŠäŒãæ¥çŒãæ¢ãã®å¡ãæ¹ â ããŒãžæ¬æãSPF 30以äžã玫å€ç·Aã»Bãå€åºçŽ15ååã2æéããšããã³æ°Žæ³³ã»æ±ã®çŽåŸã«å¡ãè¶³ããè¡£æã§èŠã£ãŠããªãç®èãéŠããæœè¡ã¯æ±ã£ãŠããªãã
ããããŠèªã
åºå ž
- ë¯žêµ FDA, BOTOX Cosmetic íê° ëŒë²š(2024) â PDF 볞묞U.S. FDA
- PMID 41612547 â Syed ë±, 목 ì ê·Œì¡ ì€ ë³Ží¡ì€ 묎ìì ìí 몚ì(ìŽë¡+PMC 볞묞)PubMed
- PMID 41560960 â Wong ë±, ê°ë¡ 목 ì£ŒëŠ íìë£šë¡ ì° ëªšì ë¶ì(ìŽë¡+PMC 볞묞)PubMed
- PMID 41873431 â Jiang ë±, ë¹ê°êµ íìë£šë¡ ì° ë³µí©ì¡ 목 ì£ŒëŠ ë¹êµ(ìŽë¡+PMC 볞묞)PubMed
- ë¯žêµ FDA, Ulthera System ìí ììœ(2012) â PDF 볞묞U.S. FDA
çŸåšã®ç¶æ ã«åãæœè¡çžè«
çŸåšã®å¥åº·ç¶æ ãšéå»ã®æœè¡æŽã確èªããããã§ãæ€èšå¯èœãªéžæè¢ãšéçããæ¡å ããŸãã



